[1] |
国家药典委员会. 中华人民共和国药典: 一部[S]. 北京: 中国医药科技出版社, 2020.Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China: Ⅰ[S]. Beijing: China medical science and technology press, 2020.
|
[2] |
钟赣生, 杨柏灿. 中药学[M]. 5版. 北京: 中国中医药出版社, 2021.ZHONG GS, YANG BC. Traditional Chinese Pharmacology[M]. 5th ed. Beijing: China press of traditional Chinese medicine, 2021.
|
[3] |
肖月星, 倪青, 闫秀峰, 等. 2型糖尿病基本证候临床表现及术语规范(一)[J]. 北京中医药, 2011, 30(3): 178-180. https://www.cnki.com.cn/Article/CJFDTOTAL-BJZO201103007.htmXIAO YX, NI Q, YAN XF, et al. Clinical manifestations and terminology standardization of the basic syndromes of type 2 diabetes(Ⅰ)[J]. Beijing J Tradit Chin Med, 2011, 30(3): 178-180. https://www.cnki.com.cn/Article/CJFDTOTAL-BJZO201103007.htm
|
[4] |
张泠杉, 王凤兰, 邢琛林, 等. 基于知识元标引的《王旭高医案》逻辑数据及知识图谱探析[J]. 南京中医药大学学报, 2021, 37(4): 592-596. doi: 10.14148/j.issn.1672-0482.2021.0592ZHANG LS, WANG FL, XING CL, et al. An exploration of the logical data and knowledge graph of Wang xugao's case records based on knowledge element indexing[J]. J Nanjing Univ Tradit Chin Med, 2021, 37(4): 592-596. doi: 10.14148/j.issn.1672-0482.2021.0592
|
[5] |
LEE D, JO M, KAHNG B. Critical behavior ofk-core percolation: Numerical studies[J]. Phys Rev E, 2016, 94(6): 62307.
|
[6] |
楼英. 医学纲目[M]. 北京: 中国中医药出版社, 1996: 454.LOU Y. An Outline of Medicine[M]. Beijing : China press of traditional Chinese medicine, 1996: 454.
|
[7] |
黄帝内经素问[M]. 北京: 人民卫生出版社, 2005.The Yellow Emperor's Inner Classic: Basic Questions[M]. Beijing: The people's medical publishing house, 2005.
|
[8] |
灵枢经[M]. 北京: 人民卫生出版社, 2005: 165.Classic of Miraculous Pivot[M]. Beijing: The people's medical publishing house, 2005: 165.
|
[9] |
高文雅, 赵海誉, 周严严, 等. 经典名方清心莲子饮的历史沿革与现代临床应用研究概况[J]. 中国实验方剂学杂志, 2021, 27(9): 224-232. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX202109032.htmGAO WY, ZHAO HY, ZHOU YY, et al. Historical evolution and modern clinical application of Qingxin Lianzi Yin[J]. Chin J Exp Tradit Med Formulae, 2021, 27(9): 224-232. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX202109032.htm
|
[10] |
王静, 蒋杰, 李新朋, 等. 天花粉治疗糖尿病物质基础及作用机制研究进展[J]. 药学研究, 2021, 40(10): 684-686, 697. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYG202110014.htmWANG J, JIANG J, LI XP, et al. Research progress on the substance basis and mechanism of Trichosanthis Radix in the treatment of diabetes mellitus[J]. J Pharm Res, 2021, 40(10): 684-686, 697. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYG202110014.htm
|
[11] |
范明明, 张嘉裕, 张湘龙, 等. 麦冬的化学成分和药理作用研究进展[J]. 中医药信息, 2020, 37(4): 130-134. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXN202004030.htmFAN MM, ZHANG JY, ZHANG XL, et al. Research progress on chemical components and pharmacological action of Radix ophiopogonis[J]. Inf Tradit Chin Med, 2020, 37(4): 130-134. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXN202004030.htm
|
[12] |
赵亚丽. 黄连素通过miR-204/SIRT1改善糖尿病胰岛β细胞功能损伤的作用机制研究[D]. 长春: 吉林大学, 2019.ZHAO YL. Berberine improves diabetic β cell damage through miR-204/SIRT1 signaling pathway[D]. Changchun: Jilin University, 2019.
|
[13] |
陈思羽, 袁前发, 王颖, 等. 黄芪多糖对高脂血症大鼠糖脂代谢及胰腺组织病理改变的影响[J]. 广东药科大学学报, 2018, 34(4): 457-461. https://www.cnki.com.cn/Article/CJFDTOTAL-GDYX201804013.htmCHEN SY, YUAN QF, WANG Y, et al. Effect of Astragalus polysaccharides on glucose and lipid metabolism and pathological changes of pancreas in rats with hyperlipidemia[J]. J Guangdong Pharm Univ, 2018, 34(4): 457-461. https://www.cnki.com.cn/Article/CJFDTOTAL-GDYX201804013.htm
|
[14] |
杨金伟, 马志辉, 赵灿, 等. 白虎加人参汤含药血浆对高糖环境下SD大鼠胰岛细胞增殖、凋亡及氧化应激水平的影响[J]. 中医杂志, 2019, 60(22): 1951-1956. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201922014.htmYANG JW, MA ZH, ZHAO C, et al. Effects of Baihu decoction plus ginseng-containing plasma on proliferation, apoptosis and oxidative stress levels in SD rat islet cells under high glucose environment[J]. J Tradit Chin Med, 2019, 60(22): 1951-1956. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201922014.htm
|